These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 27194194)
21. Neuropathic and chronic pain stimuli downregulate central mu-opioid and dopaminergic transmission. Niikura K; Narita M; Butelman ER; Kreek MJ; Suzuki T Trends Pharmacol Sci; 2010 Jul; 31(7):299-305. PubMed ID: 20471111 [TBL] [Abstract][Full Text] [Related]
22. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats. Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929 [TBL] [Abstract][Full Text] [Related]
23. Roles of different subtypes of opioid receptors in mediating the ventrolateral orbital cortex opioid-induced inhibition of mirror-neuropathic pain in the rat. Zhao M; Wang JY; Jia H; Tang JS Neuroscience; 2007 Feb; 144(4):1486-94. PubMed ID: 17184926 [TBL] [Abstract][Full Text] [Related]
31. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice. Baker AK; Meert TF J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687 [TBL] [Abstract][Full Text] [Related]
32. Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor. Pan ZZ; Tershner SA; Fields HL Nature; 1997 Sep; 389(6649):382-5. PubMed ID: 9311779 [TBL] [Abstract][Full Text] [Related]
33. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice. Kögel B; Christoph T; Strassburger W; Friderichs E Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189 [TBL] [Abstract][Full Text] [Related]
35. Approaches to improve pain relief while minimizing opioid abuse liability. Webster LR; Fine PG J Pain; 2010 Jul; 11(7):602-11. PubMed ID: 20444651 [TBL] [Abstract][Full Text] [Related]
36. New concepts in opioid analgesia. Stein C Expert Opin Investig Drugs; 2018 Oct; 27(10):765-775. PubMed ID: 30148648 [TBL] [Abstract][Full Text] [Related]
37. The role of opioid receptor phosphorylation and trafficking in adaptations to persistent opioid treatment. Johnson EE; Christie MJ; Connor M Neurosignals; 2005; 14(6):290-302. PubMed ID: 16772732 [TBL] [Abstract][Full Text] [Related]
38. Effects of kappa-opioid receptor agonists on responses to colorectal distension in rats with and without acute colonic inflammation. Burton MB; Gebhart GF J Pharmacol Exp Ther; 1998 May; 285(2):707-15. PubMed ID: 9580617 [TBL] [Abstract][Full Text] [Related]